Tirzepatide vs Semaglutide: Which GLP-1 Is Better for Weight Loss? (2026)
What Is the Difference Between Tirzepatide and Semaglutide?
Semaglutide targets one gut hormone receptor (GLP-1). Tirzepatide targets two (GLP-1 and GIP). This dual mechanism is why tirzepatide produces more weight loss.
| Semaglutide | Tirzepatide | |
|---|---|---|
| Mechanism | GLP-1 agonist (single target) | GLP-1 + GIP agonist (dual target) |
| Brand names (weight loss) | Wegovy | Zepbound |
| Brand names (diabetes) | Ozempic | Mounjaro |
| Manufacturer | Novo Nordisk | Eli Lilly |
| Dosing | Weekly injection | Weekly injection |
| FDA weight loss approval | Yes (Wegovy, 2021) | Yes (Zepbound, 2023) |
| Max weight loss dose | 2.4mg/week | 15mg/week |
How GLP-1 works: GLP-1 (glucagon-like peptide-1) slows digestion, reduces appetite, and helps regulate blood sugar. Semaglutide mimics this one hormone.
How tirzepatide adds GIP: GIP (glucose-dependent insulinotropic polypeptide) further enhances insulin secretion and appears to boost fat metabolism. By targeting both receptors, tirzepatide produces stronger appetite suppression and more weight loss than GLP-1 alone.
Tirzepatide vs Semaglutide: Weight Loss Results
Tirzepatide produces significantly more weight loss. A head-to-head comparison published in NEJM (2024) found tirzepatide achieved 20.2% average body weight loss vs 13.7% for semaglutide at comparable timeframes.
| Semaglutide | Tirzepatide | |
|---|---|---|
| Average weight loss | ~15% of body weight (STEP trials) | ~20-25% of body weight (SURMOUNT trials) |
| Head-to-head data | 13.7% (NEJM 2024) | 20.2% (NEJM 2024) |
| At 250 lbs, that’s | ~34-37 lbs lost | ~50-62 lbs lost |
| Patients losing 20%+ | ~32% (STEP) | ~57% (SURMOUNT) |
| A1C reduction (diabetes) | 1.0-2.0% | 2.0-2.5% |
| Trial duration | 68 weeks (STEP) | 72 weeks (SURMOUNT) |
Important caveats:
- Individual results vary wildly. Some people lose 30% on semaglutide; others lose 10% on tirzepatide. The averages don’t predict your outcome.
- The STEP and SURMOUNT trials had different populations. The NEJM 2024 head-to-head data is the most reliable comparison.
- Tirzepatide also lowers A1C more (2.0-2.5% vs 1.0-2.0%), making it particularly valuable for people with Type 2 diabetes.
Tirzepatide vs Semaglutide Side Effects
Side effects are similar for both medications. In clinical trials, gastrointestinal side effects occurred in approximately 50% of patients on either drug. There is no consistent evidence that one has worse side effects overall.
| Side Effect | Semaglutide | Tirzepatide |
|---|---|---|
| Nausea | 40-50% | 40-50% |
| Diarrhea | 15-20% | 15-25% |
| Constipation | 25-30% | 15-20% |
| Vomiting | 10-15% | 10-15% |
| Fatigue | ~20% | ~20% |
| Injection site reactions | <5% | <5% |
Side effects for both drugs:
- Peak during the first 2-4 weeks at each dose level, then improve
- Are dose-dependent — slow titration reduces severity
- Are the most common reason people stop treatment
- Can be managed with dietary strategies: smaller meals, avoiding fatty foods, staying hydrated
Some people tolerate one better than the other. If you have severe GI side effects on semaglutide, switching to tirzepatide (or vice versa) sometimes helps. Talk to your provider about adjusting dose timing or speed of titration.
How Much Does Tirzepatide Cost vs Semaglutide?
Semaglutide is cheaper at every price point. Compounded semaglutide starts at $129/month vs $229/month for compounded tirzepatide — a $100/month difference that adds up to $600 over 6 months.
| Option | Semaglutide | Tirzepatide |
|---|---|---|
| Brand retail | $900-1,400/mo (Ozempic/Wegovy) | $1,000-1,100/mo (Mounjaro/Zepbound) |
| LillyDirect | N/A | $299-449/mo |
| Compounded (telehealth) | $129-249/mo | $229-349/mo |
| 6-month compounded cost | $774-1,494 | $1,374-2,094 |
Which One Should You Choose?
Most people should start with semaglutide. It’s cheaper, has a longer track record, and produces excellent results for the majority. Switch to tirzepatide if you need more.
Start with semaglutide if:
- You want the most affordable option ($129/mo vs $229/mo compounded)
- You’re new to GLP-1 medications
- You want the medication with the longest track record and most safety data
- Budget is a primary concern — saves $600+ over 6 months vs tirzepatide
Choose tirzepatide if:
- You’ve plateaued on semaglutide after 6+ months and want more weight loss
- You have 100+ lbs to lose and want the strongest available option
- You have Type 2 diabetes (tirzepatide lowers A1C more: 2.0-2.5% vs 1.0-2.0%)
- Your insurance covers Zepbound/Mounjaro
- Budget isn’t the primary factor
Can you switch between them? Yes. Many people start with semaglutide and switch to tirzepatide if they plateau. Your provider will start tirzepatide at the lowest dose (2.5mg) regardless of your semaglutide dose, then titrate up. No washout period is needed.
Frequently Asked Questions
Is tirzepatide or semaglutide better for weight loss?
Tirzepatide produces more weight loss. Head-to-head data (NEJM 2024) shows 20.2% average body weight loss on tirzepatide vs 13.7% on semaglutide. In separate trials, SURMOUNT showed ~22% on tirzepatide; STEP showed ~15% on semaglutide. Both are highly effective — semaglutide is cheaper and works great for most people.
What is the difference between tirzepatide and semaglutide?
Semaglutide targets GLP-1 only (single agonist). Tirzepatide targets GLP-1 + GIP (dual agonist). This dual mechanism produces more weight loss and stronger A1C reduction. Brand names: semaglutide = Ozempic/Wegovy; tirzepatide = Mounjaro/Zepbound. Both are weekly injections.
What is the difference between Zepbound and Wegovy?
Zepbound (tirzepatide, Eli Lilly) and Wegovy (semaglutide, Novo Nordisk) are both FDA-approved for weight loss. Zepbound produces ~20-25% weight loss vs ~15% for Wegovy. Zepbound costs $1,000/mo at retail; Wegovy costs $1,300/mo. Compounded versions are $229/mo and $129/mo, respectively.
What is the difference between Mounjaro and Ozempic?
Same drugs, different labels. Mounjaro (tirzepatide) and Ozempic (semaglutide) are both FDA-approved for Type 2 diabetes. Mounjaro lowers A1C more (2.0-2.5% vs 1.0-2.0%) and produces more weight loss. Both are widely prescribed off-label for weight loss.
How much does tirzepatide cost vs semaglutide without insurance?
Compounded semaglutide: $129-249/month. Compounded tirzepatide: $229-349/month. Brand Wegovy: $1,300/mo. Brand Zepbound: $1,000/mo. LillyDirect (brand Zepbound): $299-449/mo. Full pricing guide →
Can I switch from Ozempic/Wegovy to Mounjaro/Zepbound?
Yes. Switching is common, especially after a weight loss plateau. Start tirzepatide at 2.5mg regardless of your semaglutide dose. No washout period needed. Most people notice renewed appetite suppression and additional weight loss after switching.
Do tirzepatide and semaglutide have different side effects?
Side effects are similar: nausea (~40-50%), constipation, diarrhea, fatigue. GI side effects occur in about 50% of patients on either drug. Some people tolerate one better than the other. Side effects guide →
Is it worth paying more for tirzepatide?
For most first-time GLP-1 users, no — start with semaglutide at $129/mo. It’s worth paying more for tirzepatide if you’ve plateaued on semaglutide, have Type 2 diabetes, or need more than 15% weight loss. The cost per 1% weight loss is actually similar between the two drugs.
Related Articles #
Questions? contact@glp1afterdenial.com
Affiliate Disclosure: Some links earn a small commission at no extra cost to you. I only recommend platforms I've personally researched. Medical sources: STEP trials (Wilding et al., NEJM 2021), SURMOUNT trials (Jastreboff et al., NEJM 2022), tirzepatide vs semaglutide head-to-head (NEJM 2024).